|
Market Closed -
Nasdaq
04:00:00 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 955.47 USD | +0.45% |
|
+5.65% | +23.79% |
| Market Cap | 95.88B 87B 80.37B 72.55B 137B 9,036B 142B 966B 383B 4,827B 360B 352B 15,311B | P/E 2026 * |
16.1x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 88.71B 80.49B 74.36B 67.13B 127B 8,360B 131B 894B 354B 4,466B 333B 326B 14,166B | EV / Sales 2026 * |
4.72x | EV / Sales 2027 * | 4.13x |
| Free-Float |
72.57% | Yield 2026 * |
0.4% | Yield 2027 * | 0.42% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.45% | ||
| 1 week | +5.65% | ||
| Current month | +2.97% | ||
| 1 month | +26.87% | ||
| 3 months | +18.55% | ||
| 6 months | +32.73% | ||
| Current year | +23.79% |
| 1 week | 898.29 |  | 981.55 |
| 1 month | 780.83 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
George Sing
BRD | Director/Board Member | 76 | 1988-01-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/4/26 | Exercice | SVP Controller | 11,828 | 0.0117% | ||
| 11/3/26 | Exercice | Director | 22,317 | 0.0221% | ||
| 11/3/26 | Don | Chief Technology Officer | -1,054 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | +5.65% | +37.48% | +19.93% | 95.88B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.28% | +2.43% | +35.38% | +76.94% | 439B | |
| Weighted average by Cap. | +0.54% | +3.31% | +37.63% | +94.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.81B 17.07B 15.77B 14.24B 26.85B 1,773B 27.79B 190B 75.12B 947B 70.58B 69.1B 3,004B | 20.17B 18.3B 16.9B 15.26B 28.78B 1,901B 29.78B 203B 80.52B 1,015B 75.66B 74.07B 3,220B |
| Net income | 6.43B 5.83B 5.39B 4.86B 9.17B 606B 9.49B 64.73B 25.66B 324B 24.11B 23.6B 1,026B | 6.56B 5.95B 5.5B 4.96B 9.36B 618B 9.69B 66.07B 26.19B 330B 24.61B 24.09B 1,047B |
| Net Debt | -7.17B -6.5B -6.01B -5.42B -10.23B -676B -10.59B -72.2B -28.62B -361B -26.89B -26.33B -1,145B | -12.52B -11.36B -10.49B -9.47B -17.86B -1,180B -18.49B -126B -49.98B -630B -46.96B -45.97B -1,999B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | $955.47 | +0.45% | 1,165,717 |
| 26-11-12 | $951.19 | -0.86% | 1,211,308 |
| 26-11-11 | $959.41 | +4.73% | 1,233,521 |
| 26-11-10 | $916.06 | -0.42% | 517,079 |
| 26-11-09 | $919.96 | +1.73% | 856,756 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
